KDIGO 2013 Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease
In citing this document, the following format should be used: Kidney Disease: Improving Global Outcomes (KDIGO) Lipid Work Group. KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease. Kidney inter., Suppl. 2013; 3: 259–305.
KDIGO is pleased to be able to provide the Guideline Executive Summary (Recommendation Statements only) in the following languages:
We would like to express our appreciation to all who contributed to the translation of the Lipid Management Guideline.
- Lipid Management in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2013 Clinical Practice Guideline
Annals of Internal Medicine
10 December 2013
- Implementation of the KDIGO guideline on lipid management requires a substantial increase in statin prescription rates
2 September 2015
DISCLAIMER: USE OF THE CLINICAL PRACTICE GUIDELINES
This Clinical Practice Guideline is based upon the best information available at the time of publication. The recommendations are designed to provide information and assist decision-making. They are not intended to define a standard of care, and should not be construed as one. Neither should they be interpreted as prescribing an exclusive course of management.
Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every health care professional making use of this Guideline is responsible for evaluating the appropriateness of applying them in the setting of any particular clinical situation. The recommendations for research contained within this document are general and do not imply a specific protocol.